Could neurofibromatosis (NF) be the primary cause of iron overload and hepatomegaly in this patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neurofibromatosis and Iron Overload/Hepatomegaly

No, neurofibromatosis (NF) is not a recognized cause of iron overload or hepatomegaly related to iron metabolism disorders. The evidence-based diagnostic algorithms for iron overload do not include neurofibromatosis as a differential diagnosis, and the condition is not mentioned in any major guidelines for evaluating hyperferritinemia or hepatic iron deposition 1, 2, 3.

Why NF Is Not the Cause

Neurofibromatosis causes different pathology entirely. When NF affects the gastrointestinal tract or liver, it manifests as:

  • Neurofibromas (benign nerve sheath tumors) that can occur in the intestinal wall or hepatic hilum 4, 5
  • Chronic iron deficiency anemia from recurrent GI bleeding when intestinal neurofibromas ulcerate and hemorrhage 5
  • Hematologic complications requiring bone marrow transplantation in rare cases of xanthogranuloma disseminatum 6

The pattern is opposite to iron overload: NF patients with GI involvement develop iron deficiency from chronic blood loss, not iron accumulation 5.

What Actually Causes Iron Overload and Hepatomegaly

Your diagnostic algorithm should follow this sequence:

Step 1: Measure Transferrin Saturation (TS)

  • If TS ≥45%: Suspect primary iron overload and proceed to HFE genetic testing for C282Y and H63D mutations 1, 2
  • If TS <45%: Iron overload is unlikely; focus on secondary causes of hyperferritinemia 2, 3

Step 2: Common Causes (>90% of cases)

The following account for over 90% of hyperferritinemia cases 2:

  • Chronic alcohol consumption (increases iron absorption and causes hepatocellular injury) 1, 2
  • Non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome 2, 3
  • Inflammation (ferritin is an acute phase reactant) 2, 3
  • Cell necrosis (releases ferritin from damaged hepatocytes) 2
  • Malignancy (solid tumors, lymphomas, hepatocellular carcinoma) 2

Step 3: If C282Y Homozygous

  • Confirms HFE hemochromatosis 1
  • Ferritin >1000 μg/L with elevated ALT and platelets <200: 80% risk of cirrhosis, requires liver biopsy 1, 2
  • Ferritin <1000 μg/L, normal liver enzymes, age <40: Can proceed to phlebotomy without biopsy 1, 2

Step 4: If Not C282Y Homozygous

Consider 1, 3:

  • Non-HFE hemochromatosis (TFR2, SLC40A1, HAMP, HJV mutations) 1, 2
  • Ferroportin disease (SLC40A1 mutations causing iron retention in macrophages) 1
  • Aceruloplasminemia (CP gene defects with hepatic and CNS iron deposition) 1
  • Secondary iron overload from:
    • Chronic liver disease (viral hepatitis B/C, alcoholic liver disease) 2, 3
    • Hematologic disorders (thalassemia, myelodysplastic syndrome, sickle cell disease) 3
    • Transfusional iron overload 3

Critical Diagnostic Pitfalls to Avoid

Never use ferritin alone to diagnose iron overload. Ferritin is an acute phase reactant elevated in inflammation, liver disease, malignancy, and tissue necrosis independent of actual iron stores 1, 2, 3.

Do not overlook liver biopsy when ferritin >1000 μg/L with abnormal liver tests. This combination has 100% sensitivity for cirrhosis in hemochromatosis patients 1, 2.

Do not assume iron overload when TS <45%. In the general population, iron overload is NOT the most common cause of elevated ferritin 2.

Role of MRI in Unclear Cases

MRI R2 quantification should be used when:*

  • Diagnosis remains uncertain after genetic testing 7, 8
  • Non-C282Y homozygous genotype with biochemical iron overload 7, 8
  • Need to quantify hepatic iron concentration and predict phlebotomy requirements 7, 8
  • Assessing for cardiac iron deposition in severe cases 7, 8

MRI has replaced liver biopsy as the standard for iron quantification due to superior sensitivity, specificity, and lack of sampling error 7, 8.

Bottom Line

Neurofibromatosis is not part of the differential diagnosis for iron overload. If your patient has both NF and iron overload/hepatomegaly, these are separate, unrelated conditions requiring independent evaluation. Follow the standard iron overload diagnostic algorithm starting with transferrin saturation and HFE genetic testing 1, 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperferritinemia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Iron overload disorders.

Hepatology communications, 2022

Guideline

MRI in Hemochromatosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Imaging Recommendations for Hemochromatosis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.